Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysis-Reference-Cited by-同舟云学术

Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysis

Published:2019-08 Issue:4 Volume:17 Page:e806-e813
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Landre Thierry,Guetz Gaetan Des,Chouahnia Kader,Fossey-Diaz Virginie,Taleb Cherifa,Culine Stephane

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Management of prostate cancer in elderly patients: recommendations of a task force of the International Society of Geriatric Oncology;Droz;Eur Urol,2017

2. Prostate cancer management in an ageing population;Grummet;Eur Urol,2017

3. Prostate cancer in the elderly;Heinzer;Urol Oncol,2009

4. Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: a network meta-analysis;Feyerabend;Eur J Cancer,2018

5. The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation;McNamara;Prostate Cancer Prostatic Dis,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Treatment for Metastatic Hormone-Sensitive Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses;Cancers;2023-12-06

2. The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer;Cancers;2023-11-16

3. Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer;Journal of the National Comprehensive Cancer Network;2022-10

4. Origin and Therapies of Osteosarcoma;Cancers;2022-07-19

5. Advanced Prostate Cancer: Treatment Advances and Future Directions;Trends in Cancer;2020-08